Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
713 8 |
Ultima descărcare din IBN: 2021-12-22 19:10 |
Căutarea după subiecte similare conform CZU |
615.322 (214) |
Medicamentele potrivit originii lor (470) |
SM ISO690:2012 APOSTOL, Theodora-Venera, SOCEA, Laura-Ileana, BARBUCEANU, Stefania-Felicia, SARAMET, Ioana, OLARU, Octavian-Tudorel, DRAGHICI, Constantin C.. Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]-
4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles
. In: Revista Farmaceutică a Moldovei , 2014, nr. 3-4, p. 45. ISSN 1812-5077. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista Farmaceutică a Moldovei | |
Numărul 3-4 / 2014 / ISSN 1812-5077 | |
|
|
CZU: 615.322 | |
Pag. 45-45 | |
Descarcă PDF | |
Rezumat | |
Heterocyclic compounds containing 1,3-oxazol-5(4H)-one and 1,3-oxazole ring are important targets in synthetic and medicinal chemistry, because of their applications as potentially active compounds. Thus, some 1,3-oxazol-5(4H)-ones have been reported to present antimicrobial and antitumor activity. 1,3-Oxazoles are frequent substructures in various biologically active compounds used in therapeutics as anti-inflammatory (e.g. Oxaprozin, Romazarit, Ditazol, Isamoxole), analgesic (e.g. Oxaprozin), antibacterial, antifungal (e.g. Sulfamoxole, Sulfaguanole), muscle relaxant (e.g. Azumolene) drugs. Therefore, there is considerable interest to synthesize new 1,3-oxazole5(4H)-ones and 1,3-oxazoles which contain 4-(4-bromophenylsulfonyl) phenyl moiety in 2 position with a hope to obtain potent biologically active compounds. The plant growth regulatory effects of the new compounds were examined. |
|
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-41644</cfResPublId> <cfResPublDate>2014-12-11</cfResPublDate> <cfIssue>3-4</cfIssue> <cfStartPage>45</cfStartPage> <cfISSN>1812-5077</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/41644</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]- 4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles </cfTitle> <cfAbstr cfLangCode='EN' cfTrans='o'>Heterocyclic compounds containing 1,3-oxazol-5(4H)-one and 1,3-oxazole ring are important targets in synthetic and medicinal chemistry, because of their applications as potentially active compounds. Thus, some 1,3-oxazol-5(4H)-ones have been reported to present antimicrobial and antitumor activity. 1,3-Oxazoles are frequent substructures in various biologically active compounds used in therapeutics as anti-inflammatory (e.g. Oxaprozin, Romazarit, Ditazol, Isamoxole), analgesic (e.g. Oxaprozin), antibacterial, antifungal (e.g. Sulfamoxole, Sulfaguanole), muscle relaxant (e.g. Azumolene) drugs. Therefore, there is considerable interest to synthesize new 1,3-oxazole5(4H)-ones and 1,3-oxazoles which contain 4-(4-bromophenylsulfonyl) phenyl moiety in 2 position with a hope to obtain potent biologically active compounds. The plant growth regulatory effects of the new compounds were examined. </cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-53268</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-53269</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-53270</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-53271</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-45697</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-53272</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-53268</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-53268-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> <cfFamilyNames>Apostol</cfFamilyNames> <cfFirstNames>Theodora-Venera</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-53269</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-53269-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> <cfFamilyNames>Socea</cfFamilyNames> <cfFirstNames>Laura-Ileana</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-53270</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-53270-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> <cfFamilyNames>Barbuceanu</cfFamilyNames> <cfFirstNames>Stefania-Felicia</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-53271</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-53271-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> <cfFamilyNames>Saramet</cfFamilyNames> <cfFirstNames>Ioana</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-45697</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-45697-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> <cfFamilyNames>Olaru</cfFamilyNames> <cfFirstNames>Octavian-Tudorel</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-53272</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-53272-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2014-12-11T24:00:00</cfStartDate> <cfFamilyNames>Draghici</cfFamilyNames> <cfFirstNames>Constantin C.</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>